[1] 杨艳华.近30年来慢性心力衰竭住院患者合并肾功能不全的回顾性分析[J].天津医药,2009,37(4):261-265. [2] 刘琳琳,黎辉. 预防心衰患者发生肾功能不全[J].心脏杂志,2014,16(3):366-369. [3] 钱烨晟,卢辉和,于洋,等. 可溶性ST2联合白细胞介素33对老年慢性肾功能不全患者心力衰竭的临床观察[J].中华老年心脑血管病杂志,2018,20(12):1270-1273. [4] 张宇,李新,冷晓,等. 不同血清钠离子水平对高龄心力衰竭患者心功能和预后的影响[J].中华老年医学杂志,2018,37(9):962-965. [5] PONIKOWSKI P,VOORS AA,ANKER SD,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J].Eur J Heart Fail,2016,18(8):891-975. [6] 陈孝平,汪建平.外科学[M].第8版.北京:人民卫生出版社,2013:12-13. [7] 刘宝兰,刘生友. 醋酸去氨加压素致重度低钠血症1例[J].医药导报,2018,37(11):1419-1420. [8] 张宇. 870 例老年住院患者血钠和血钾水平及其紊乱危险因素分析[J].中华老年医学杂志,2016,35(6):572-576. [9] 杜国芳. 托伐普坦治疗老年慢性心力衰竭合并低钠血症的临床疗效观察[J].山西医药杂志, 2017,46(23):2919-2920. [10] SCHARTUM-HANSEN H.Use of loop diuretics is associated with increased mortality in patients with suspected coronary artery disease,but without systolic heart failure or renal impairment :An observational study using propensity score matching[J].PLoS One,2015,10(6):1-13.
2022, Vol. 39 
